Drug Shortage Report for VASOPRESSIN INJECTION, USP
| Report ID | 3988 |
| Drug Identification Number | 02139502 |
| Brand name | VASOPRESSIN INJECTION |
| Common or Proper name | Vasopressin Injection, USP 20 units/mL MD Vial 1 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | VASOPRESSIN |
| Strength(s) | 20UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 1mL |
| ATC code | H01BA |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2017-02-16 |
| Estimated end date | 2017-04-20 |
| Actual end date | 2017-04-20 |
| Shortage status | Resolved |
| Updated date | 2017-04-21 |
| Company comments | Reduced allocation will no longer be in effect as of Thursday April 20th. Product will be available to all customers through all distribution channels without any volume restrictions. Please contact Fresenius Kabi Customer Service for further information. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2017-04-21 | English | Compare |
| v9 | 2017-04-13 | French | Compare |
| v8 | 2017-04-13 | English | Compare |
| v7 | 2017-03-23 | English | Compare |
| v6 | 2017-03-23 | French | Compare |
| v5 | 2017-03-23 | English | Compare |
| v4 | 2017-03-22 | French | Compare |
| v3 | 2017-03-22 | French | Compare |
| v2 | 2017-03-22 | English | Compare |
| v1 | 2017-03-22 | English | Compare |
Showing 1 to 10 of 10